Ask for hepatic and renal function tests (baseline alkaline phosphatase, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin).

Before starting treatment, pregnancy test in females of child-bearing age.

In the first year, assess transaminases every month or before any rise in the dosage (whichever happens first), and afterward every three months minimally and before increasing the dose.

Check other medications that patients might be administering; adjusting doses or alternative treatments might be required.

Check signs of severe diarrhea or hepatic toxicity.

**For Nurses**

Assess abnormalities in the ordered labs and reports.

Monitor for and inform the patient to report severe diarrhea or any signs of hepatic toxicity, for example, loss of appetite, serious abdominal pain, jaundice, dark urine, or light-colored feces.